Picture of Climb Bio logo

CLYM — Climb Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Climb Bio Reports Fourth Quarter And Year-End 2024 Financial Results And Provides Business Updates

March 25 (Reuters) - Climb Bio Inc CLYM.O:

CLIMB BIO REPORTS FOURTH QUARTER AND YEAR-END 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

CLIMB BIO INC - EXPECTS CASH RUNWAY THROUGH 2027

CLIMB BIO INC: QTRLY  LOSS PER SHARE $0.13

Source text: ID:nGNX3b6NF6

Further company coverage: CLYM.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Climb Bio

See all news